These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25545858)

  • 61. Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Faessel H; Ravva P; Williams K
    Clin Ther; 2009 Jan; 31(1):177-89. PubMed ID: 19243716
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial.
    Gray KM; Baker NL; McClure EA; Tomko RL; Squeglia LM; Saladin ME; Carpenter MJ
    JAMA Pediatr; 2019 Dec; 173(12):1146-1153. PubMed ID: 31609433
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gastrointestinal adverse effects of varenicline at maintenance dose: a meta-analysis.
    Leung LK; Patafio FM; Rosser WW
    BMC Clin Pharmacol; 2011 Sep; 11():15. PubMed ID: 21955317
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Perceived medication assignment during a placebo-controlled laboratory study of varenicline: temporal associations of treatment expectancies with smoking-related outcomes.
    Correa JB; Heckman BW; Marquinez NS; Drobes DJ; Unrod M; Roetzheim RG; Brandon TH
    Psychopharmacology (Berl); 2014 Jul; 231(13):2559-66. PubMed ID: 24408212
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers.
    McClure EA; Baker NL; Gipson CD; Carpenter MJ; Roper AP; Froeliger BE; Kalivas PW; Gray KM
    Am J Drug Alcohol Abuse; 2015 Jan; 41(1):52-6. PubMed ID: 25062287
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.
    Anthenelli RM; Morris C; Ramey TS; Dubrava SJ; Tsilkos K; Russ C; Yunis C
    Ann Intern Med; 2013 Sep; 159(6):390-400. PubMed ID: 24042367
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.
    Anthenelli RM; Benowitz NL; West R; St Aubin L; McRae T; Lawrence D; Ascher J; Russ C; Krishen A; Evins AE
    Lancet; 2016 Jun; 387(10037):2507-20. PubMed ID: 27116918
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study).
    Tsukahara H; Noda K; Saku K
    Circ J; 2010 Apr; 74(4):771-8. PubMed ID: 20154405
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment.
    Hajek P; Tønnesen P; Arteaga C; Russ C; Tonstad S
    Addiction; 2009 Sep; 104(9):1597-602. PubMed ID: 19686530
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effects of varenicline on attention and inhibitory control among treatment-seeking smokers.
    Rhodes JD; Hawk LW; Ashare RL; Schlienz NJ; Mahoney MC
    Psychopharmacology (Berl); 2012 Sep; 223(2):131-8. PubMed ID: 22526531
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
    Lam S; Patel PN
    Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients.
    Tashkin DP; Rennard S; Taylor Hays J; Lawrence D; Marton JP; Lee TC
    Respir Med; 2011 Nov; 105(11):1682-90. PubMed ID: 21621992
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Abstinence and relapse among smokers who use varenicline in a quit attempt-a pooled analysis of randomized controlled trials.
    Agboola SA; Coleman T; McNeill A; Leonardi-Bee J
    Addiction; 2015 Jul; 110(7):1182-93. PubMed ID: 25846123
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study.
    Cui Q; Robinson L; Elston D; Smaill F; Cohen J; Quan C; McFarland N; Thabane L; McIvor A; Zeidler J; Smieja M
    AIDS Patient Care STDS; 2012 Jan; 26(1):12-9. PubMed ID: 22007690
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial.
    Hitsman B; Papandonatos GD; Gollan JK; Huffman MD; Niaura R; Mohr DC; Veluz-Wilkins AK; Lubitz SF; Hole A; Leone FT; Khan SS; Fox EN; Bauer AM; Wileyto EP; Bastian J; Schnoll RA
    Addiction; 2023 Sep; 118(9):1710-1725. PubMed ID: 37069490
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial.
    Courtney RJ; McRobbie H; Tutka P; Weaver NA; Petrie D; Mendelsohn CP; Shakeshaft A; Talukder S; Macdonald C; Thomas D; Kwan BCH; Walker N; Gartner C; Mattick RP; Paul C; Ferguson SG; Zwar NA; Richmond RL; Doran CM; Boland VC; Hall W; West R; Farrell M
    JAMA; 2021 Jul; 326(1):56-64. PubMed ID: 34228066
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical experience of varenicline for smoking cessation.
    Jung JW; Jeon EJ; Kim JG; Yang SY; Choi JC; Shin JW; Park IW; Choi BW; Kim DK; Kim JY
    Clin Respir J; 2010 Oct; 4(4):215-21. PubMed ID: 20887344
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers.
    Ashare RL; Tang KZ; Mesaros AC; Blair IA; Leone F; Strasser AA
    J Psychopharmacol; 2012 Oct; 26(10):1383-90. PubMed ID: 22695488
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation.
    Faessel HM; Obach RS; Rollema H; Ravva P; Williams KE; Burstein AH
    Clin Pharmacokinet; 2010 Dec; 49(12):799-816. PubMed ID: 21053991
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interventions to increase adherence to medications for tobacco dependence.
    Hollands GJ; McDermott MS; Lindson-Hawley N; Vogt F; Farley A; Aveyard P
    Cochrane Database Syst Rev; 2015 Feb; (2):CD009164. PubMed ID: 25914910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.